Header Logo

Connection

ROY F CHEMALY to Humans

Back to Details
This is a "connection" page, showing publications ROY F CHEMALY has written about Humans.
ROY F CHEMALY
Connection Strength
1.469
Humans
  1. COVID-19 in cancer patients: The impact of vaccination on outcomes early in the pandemic. Cancer Med. 2023 12; 12(24):22006-22022.
    View in: PubMed
    Score: 0.019
  2. Utility of Bronchoalveolar Lavage for the Diagnosis and Management of COVID-19 in Patients With Cancer. J Infect Dis. 2023 11 28; 228(11):1549-1558.
    View in: PubMed
    Score: 0.019
  3. The impact of the COVID-19 pandemic on hospital-acquired infections at a comprehensive cancer center. Am J Infect Control. 2023 12; 51(12):1302-1308.
    View in: PubMed
    Score: 0.018
  4. American Society of Transplantation and Cellular Therapy Series: #7 - Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients. Transplant Cell Ther. 2023 Dec; 29(12):730-738.
    View in: PubMed
    Score: 0.018
  5. Clinical trials for treatment of respiratory viral infections in recipients of haematopoietic cell transplantation and cellular therapies: are we on the right path to the finish line? Clin Microbiol Infect. 2024 Mar; 30(3):270-275.
    View in: PubMed
    Score: 0.018
  6. Hematopoietic cell transplantation can be safely performed after COVID-19. Bone Marrow Transplant. 2023 12; 58(12):1410-1412.
    View in: PubMed
    Score: 0.018
  7. Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology. Transplant Cell Ther. 2023 01; 29(1):10-18.
    View in: PubMed
    Score: 0.017
  8. How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies. Blood. 2022 08 18; 140(7):673-684.
    View in: PubMed
    Score: 0.017
  9. Nosocomial COVID-19 at a comprehensive cancer center during the first year of the pandemic: Lessons learned. Am J Infect Control. 2023 05; 51(5):506-513.
    View in: PubMed
    Score: 0.017
  10. Acute and latent viral infections in immunocompromised patients: a tale of brave battles and menacing foes. Clin Microbiol Infect. 2022 10; 28(10):1319-1320.
    View in: PubMed
    Score: 0.017
  11. Predicting risk of progression to lower respiratory tract infection in allogeneic hematopoietic cell transplant recipients with respiratory viral infections: where are we now? Bone Marrow Transplant. 2022 05; 57(5):701-702.
    View in: PubMed
    Score: 0.017
  12. Emergence and Transmission of Daptomycin and Vancomycin-Resistant Enterococci Between Patients and Hospital Rooms. Clin Infect Dis. 2021 12 16; 73(12):2306-2313.
    View in: PubMed
    Score: 0.016
  13. Combination of baloxavir and oseltamivir for treatment of severe influenza infection in hematopoietic cell transplant recipients: a novel treatment strategy for a high-risk population. Microbes Infect. 2022 Apr-May; 24(3):104895.
    View in: PubMed
    Score: 0.016
  14. Refractory and Resistant Cytomegalovirus After Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era. Clin Infect Dis. 2021 10 20; 73(8):1346-1354.
    View in: PubMed
    Score: 0.016
  15. DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled Study. Clin Infect Dis. 2021 08 02; 73(3):e773-e781.
    View in: PubMed
    Score: 0.016
  16. The ever-growing world of infections in immunocompromised patients: major headways with numerous shortcomings. Clin Microbiol Infect. 2021 10; 27(10):1379-1380.
    View in: PubMed
    Score: 0.016
  17. Immune reconstitution and severity of COVID-19 among hematopoietic cell transplant recipients. Transpl Infect Dis. 2021 Aug; 23(4):e13606.
    View in: PubMed
    Score: 0.016
  18. Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access program. BMC Infect Dis. 2021 Jan 11; 21(1):46.
    View in: PubMed
    Score: 0.015
  19. A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients. Clin Infect Dis. 2020 12 31; 71(11):2777-2786.
    View in: PubMed
    Score: 0.015
  20. Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study. Clin Infect Dis. 2020 12 03; 71(9):2365-2374.
    View in: PubMed
    Score: 0.015
  21. Surveillance and identification of clusters of healthcare workers with coronavirus disease 2019 (COVID-19): Multidimensional interventions at a comprehensive cancer center. Infect Control Hosp Epidemiol. 2021 07; 42(7):797-802.
    View in: PubMed
    Score: 0.015
  22. Brincidofovir: understanding its unique profile and potential role against adenovirus and other viral infections. Future Microbiol. 2020 04; 15:389-400.
    View in: PubMed
    Score: 0.014
  23. Disseminated cytomegalovirus infection with bilateral adrenal pseudotumors masquerading as recurrent hematologic malignancy. Infection. 2020 Jun; 48(3):477-481.
    View in: PubMed
    Score: 0.014
  24. Resistant or refractory cytomegalovirus infections after hematopoietic cell transplantation: diagnosis and management. Curr Opin Infect Dis. 2019 12; 32(6):565-574.
    View in: PubMed
    Score: 0.014
  25. Reply to Jain et al. Clin Infect Dis. 2019 11 27; 69(12):2235-2236.
    View in: PubMed
    Score: 0.014
  26. Active Mycobacterium tuberculosis infection at a comprehensive cancer center, 2006-2014. BMC Infect Dis. 2019 Nov 06; 19(1):934.
    View in: PubMed
    Score: 0.014
  27. Clinical and economic burden of pre-emptive therapy of cytomegalovirus infection in hospitalized allogeneic hematopoietic cell transplant recipients. J Med Virol. 2020 01; 92(1):86-95.
    View in: PubMed
    Score: 0.014
  28. Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies. Haematologica. 2019 07; 104(7):1322-1331.
    View in: PubMed
    Score: 0.014
  29. A Systematic and Critical Review of Bacteriophage Therapy Against Multidrug-resistant ESKAPE Organisms in Humans. Clin Infect Dis. 2019 06 18; 69(1):167-178.
    View in: PubMed
    Score: 0.014
  30. Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients. Clin Infect Dis. 2019 05 02; 68(10):1641-1649.
    View in: PubMed
    Score: 0.014
  31. Reply to Gim?nez et al. J Infect Dis. 2019 04 16; 219(9):1512-1513.
    View in: PubMed
    Score: 0.014
  32. Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials. Clin Infect Dis. 2019 04 08; 68(8):1420-1426.
    View in: PubMed
    Score: 0.014
  33. The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients. J Infect Dis. 2019 02 23; 219(6):898-907.
    View in: PubMed
    Score: 0.013
  34. In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: A systematic literature review. Antiviral Res. 2019 03; 163:50-58.
    View in: PubMed
    Score: 0.013
  35. Paramyxovirus infections in hematopoietic cell transplant recipients. Curr Opin Infect Dis. 2018 12; 31(6):542-552.
    View in: PubMed
    Score: 0.013
  36. Viral therapeutics: where we are and where we are going. Curr Opin Infect Dis. 2018 12; 31(6):512-513.
    View in: PubMed
    Score: 0.013
  37. Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection. J Antimicrob Chemother. 2018 11 01; 73(11):3162-3169.
    View in: PubMed
    Score: 0.013
  38. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies. Transpl Infect Dis. 2018 Dec; 20(6):e12994.
    View in: PubMed
    Score: 0.013
  39. Letermovir for the prevention of cytomegalovirus infection in adult cytomegalovirus-seropositive hematopoietic stem cell transplant recipients. Expert Rev Clin Pharmacol. 2018 Oct; 11(10):931-941.
    View in: PubMed
    Score: 0.013
  40. Update on infection control practices in cancer hospitals. CA Cancer J Clin. 2018 09; 68(5):340-355.
    View in: PubMed
    Score: 0.013
  41. Evaluation of a pulsed xenon ultraviolet disinfection system to decrease bacterial contamination in operating rooms. BMC Infect Dis. 2017 10 10; 17(1):672.
    View in: PubMed
    Score: 0.012
  42. Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes. Cancer. 2017 Jun 15; 123(12):2329-2337.
    View in: PubMed
    Score: 0.012
  43. Antiviral therapy for respiratory viral infections in immunocompromised patients. Expert Rev Anti Infect Ther. 2017 04; 15(4):401-415.
    View in: PubMed
    Score: 0.012
  44. The characteristics of patients with mycobacterium tuberculosis blood stream infections in Beijing, China: a retrospective study. BMC Infect Dis. 2016 Dec 12; 16(1):750.
    View in: PubMed
    Score: 0.012
  45. How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients. Blood. 2016 12 08; 128(23):2624-2636.
    View in: PubMed
    Score: 0.011
  46. Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series. Antiviral Res. 2016 11; 135:91-96.
    View in: PubMed
    Score: 0.011
  47. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience. Antiviral Res. 2016 10; 134:58-62.
    View in: PubMed
    Score: 0.011
  48. Challenges in Determining Genotypes for Pharmacogenetics in Allogeneic Hematopoietic Cell Transplant Recipients. J Mol Diagn. 2016 09; 18(5):638-642.
    View in: PubMed
    Score: 0.011
  49. High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-?-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center. Clin Infect Dis. 2016 10 01; 63(7):954-958.
    View in: PubMed
    Score: 0.011
  50. Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review. Cancer Lett. 2016 08 28; 379(1):100-6.
    View in: PubMed
    Score: 0.011
  51. Utility of the Enzyme-Linked Immunospot Interferon-?-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients. J Infect Dis. 2016 Jun 01; 213(11):1701-7.
    View in: PubMed
    Score: 0.011
  52. Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring Index. Biol Blood Marrow Transplant. 2016 Mar; 22(3):542-8.
    View in: PubMed
    Score: 0.011
  53. Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients. J Antimicrob Chemother. 2016 Mar; 71(3):727-30.
    View in: PubMed
    Score: 0.011
  54. Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review. Cancer Lett. 2016 Jan 28; 370(2):358-64.
    View in: PubMed
    Score: 0.011
  55. Innovative Analysis of the Sequenced Patterns of Vancomycin-Resistant Enterococci Strains to Determine Clonal Transmission in a Hospital Setting. Infect Control Hosp Epidemiol. 2015 Dec; 36(12):1461-3.
    View in: PubMed
    Score: 0.011
  56. Influenza vaccination in patients with cancer: factors associated with vaccination practices for patients and their household members. Infect Control Hosp Epidemiol. 2015 Oct; 36(10):1239-41.
    View in: PubMed
    Score: 0.010
  57. Practical review of immunizations in adult patients with cancer. Hum Vaccin Immunother. 2015; 11(11):2606-14.
    View in: PubMed
    Score: 0.010
  58. Non-inferiority of pulsed xenon UV light versus bleach for reducing environmental Clostridium difficile contamination on high-touch surfaces in Clostridium difficile infection isolation rooms. J Med Microbiol. 2015 Feb; 64(Pt 2):191-4.
    View in: PubMed
    Score: 0.010
  59. Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice. Transpl Infect Dis. 2014 Dec; 16(6):878-86.
    View in: PubMed
    Score: 0.010
  60. Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies. Clin Infect Dis. 2014 Nov 15; 59 Suppl 5:S344-51.
    View in: PubMed
    Score: 0.010
  61. Cluster and sporadic cases of herbaspirillum species infections in patients with cancer. Clin Infect Dis. 2015 Jan 01; 60(1):48-54.
    View in: PubMed
    Score: 0.010
  62. Infection control practices in patients with hematological malignancies and multidrug-resistant organisms: special considerations and challenges. Clin Lymphoma Myeloma Leuk. 2014 Sep; 14 Suppl:S104-10.
    View in: PubMed
    Score: 0.010
  63. The use of fidaxomicin for treatment of relapsed Clostridium difficile infections in patients with cancer. Pharmacotherapy. 2014 Nov; 34(11):1220-5.
    View in: PubMed
    Score: 0.010
  64. CMV prophylaxis in hematopoietic-cell transplantation. N Engl J Med. 2014 08 07; 371(6):576-7.
    View in: PubMed
    Score: 0.010
  65. Respiratory syncytial virus infections in children with cancer. J Pediatr Hematol Oncol. 2014 Aug; 36(6):e376-81.
    View in: PubMed
    Score: 0.010
  66. Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections. Blood. 2014 May 22; 123(21):3263-8.
    View in: PubMed
    Score: 0.010
  67. Perioperative antimicrobial prophylaxis for intra-abdominal surgery in patients with cancer: a retrospective study comparing ertapenem and nonertapenem antibiotics. Ann Surg Oncol. 2014 Feb; 21(2):513-9.
    View in: PubMed
    Score: 0.009
  68. Cytomegalovirus diseases after hematopoietic stem cell transplantation: a mini-review. Cancer Lett. 2014 Jan 01; 342(1):1-8.
    View in: PubMed
    Score: 0.009
  69. Reply to Robinson. J Infect Dis. 2013 Sep 01; 208(5):864-5.
    View in: PubMed
    Score: 0.009
  70. Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections. J Antimicrob Chemother. 2013 Aug; 68(8):1872-80.
    View in: PubMed
    Score: 0.009
  71. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection. 2013 Oct; 41(5):1039-40.
    View in: PubMed
    Score: 0.009
  72. Reply to F?tkenheuer et al. J Infect Dis. 2013 May 15; 207(10):1622-3.
    View in: PubMed
    Score: 0.009
  73. An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection. J Infect Dis. 2012 Nov; 206(9):1367-71.
    View in: PubMed
    Score: 0.009
  74. Antimicrobial stewardship in patients with cancer. Pharmacotherapy. 2012 Aug; 32(8):722-34.
    View in: PubMed
    Score: 0.009
  75. Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center. Oncologist. 2012; 17(10):1329-36.
    View in: PubMed
    Score: 0.008
  76. Characteristics and outcomes of pandemic 2009/H1N1 versus seasonal influenza in children with cancer. Pediatr Infect Dis J. 2012 Apr; 31(4):373-8.
    View in: PubMed
    Score: 0.008
  77. A multicenter study of pandemic influenza A (H1N1) infection in patients with solid tumors in 3 countries: early therapy improves outcomes. Cancer. 2012 Sep 15; 118(18):4627-33.
    View in: PubMed
    Score: 0.008
  78. The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation. Blood. 2012 Mar 22; 119(12):2738-45; quiz 2969.
    View in: PubMed
    Score: 0.008
  79. Antimicrobial de-escalation in cancer patients. Infection. 2012 Apr; 40(2):223-4; author reply 229-30.
    View in: PubMed
    Score: 0.008
  80. Novel intervention for eliminating VRE from the environment. Arch Intern Med. 2011 Oct 10; 171(18):1684-5.
    View in: PubMed
    Score: 0.008
  81. Serratia marcescens bacteremia because of contaminated prefilled heparin and saline syringes: a multi-state report. Am J Infect Control. 2011 Aug; 39(6):521-4.
    View in: PubMed
    Score: 0.008
  82. Outbreak of community-acquired methicillin-resistant Staphylococcus aureus skin infections among health care workers in a cancer center. Am J Infect Control. 2011 Mar; 39(2):112-7.
    View in: PubMed
    Score: 0.008
  83. Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood. 2011 Mar 10; 117(10):2755-63.
    View in: PubMed
    Score: 0.008
  84. Viral pneumonias in immunocompromised adult hosts. J Intensive Care Med. 2010 Nov-Dec; 25(6):307-26.
    View in: PubMed
    Score: 0.007
  85. Valacyclovir: approved and off-label uses for the treatment of herpes virus infections in immunocompetent and immunocompromised adults. Expert Opin Pharmacother. 2010 Aug; 11(11):1901-13.
    View in: PubMed
    Score: 0.007
  86. Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab. Biol Blood Marrow Transplant. 2010 Sep; 16(9):1265-71.
    View in: PubMed
    Score: 0.007
  87. Characteristics and outcomes of methicillin-resistant Staphylococcus aureus surgical-site infections in patients with cancer: a case-control study. Ann Surg Oncol. 2010 Jun; 17(6):1499-506.
    View in: PubMed
    Score: 0.007
  88. The efficacy of catheters coated with minocycline and rifampin in the prevention of catheter-related bacteremia in cancer patients receiving high-dose interleukin-2. Int J Infect Dis. 2010 Jul; 14(7):e548-52.
    View in: PubMed
    Score: 0.007
  89. A tertiary care cancer center experience of the 2007 outbreak of Serratia marcescens bloodstream infection due to prefilled syringes. Infect Control Hosp Epidemiol. 2009 Dec; 30(12):1237-8.
    View in: PubMed
    Score: 0.007
  90. Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution. Medicine (Baltimore). 2009 Jul; 88(4):211-220.
    View in: PubMed
    Score: 0.007
  91. Palivizumab: where to from here? Expert Opin Biol Ther. 2009 Jan; 9(1):139-47.
    View in: PubMed
    Score: 0.007
  92. Herpes simplex virus lower respiratory tract infection in patients with solid tumors. Cancer. 2009 Jan 01; 115(1):199-206.
    View in: PubMed
    Score: 0.007
  93. Fatal cytomegalovirus pneumonia in patients with haematological malignancies: an autopsy-based case-control study. Clin Microbiol Infect. 2008 Dec; 14(12):1160-6.
    View in: PubMed
    Score: 0.007
  94. Human herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection. Haematologica. 2008 Jan; 93(1):157-8.
    View in: PubMed
    Score: 0.006
  95. Viral infection or reactivation in patients during treatment with dasatinib: a call for screening? Leuk Lymphoma. 2007 Dec; 48(12):2308-9.
    View in: PubMed
    Score: 0.006
  96. Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia. Haematologica. 2007 Sep; 92(9):1216-23.
    View in: PubMed
    Score: 0.006
  97. Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study. Clin Infect Dis. 2007 Apr 01; 44(7):964-7.
    View in: PubMed
    Score: 0.006
  98. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore). 2006 Sep; 85(5):278-287.
    View in: PubMed
    Score: 0.006
  99. Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality. Clin Lymphoma Myeloma. 2006 Mar; 6(5):393-8.
    View in: PubMed
    Score: 0.005
  100. Cytomegalovirus pneumonia in patients with lymphoma. Cancer. 2005 Sep 15; 104(6):1213-20.
    View in: PubMed
    Score: 0.005
  101. Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer. 2005 Oct; 41(15):2268-79.
    View in: PubMed
    Score: 0.005
  102. Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients. Am J Transplant. 2005 Mar; 5(3):544-8.
    View in: PubMed
    Score: 0.005
  103. Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry. J Clin Microbiol. 2004 May; 42(5):2168-72.
    View in: PubMed
    Score: 0.005
  104. Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study. Clin Infect Dis. 2024 03 20; 78(3):775-784.
    View in: PubMed
    Score: 0.005
  105. Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients. J Infect Dis. 2024 Feb 14; 229(2):413-421.
    View in: PubMed
    Score: 0.005
  106. An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab. Cancer Med. 2024 Feb; 13(3):e6997.
    View in: PubMed
    Score: 0.005
  107. Post-transplantation cyclophosphamide is associated with increased bacterial infections. Bone Marrow Transplant. 2024 01; 59(1):76-84.
    View in: PubMed
    Score: 0.005
  108. CMV prevention strategies in allogeneic hematopoietic cell transplantation; the role of prophylaxis and pre-emptive monitoring in the era of letermovir. Transpl Infect Dis. 2023 Nov; 25 Suppl 1:e14171.
    View in: PubMed
    Score: 0.005
  109. Incidence and Impact of Fungal Infections in Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis and Haploidentical Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis. Transplant Cell Ther. 2024 Jan; 30(1):114.e1-114.e16.
    View in: PubMed
    Score: 0.005
  110. Rotaviral and bacterial gastroenteritis in children during winter: an evaluation of physician ordering patterns. J Clin Virol. 2003 Sep; 28(1):44-50.
    View in: PubMed
    Score: 0.005
  111. Microbiology of liver abscesses and the predictive value of abscess gram stain and associated blood cultures. Diagn Microbiol Infect Dis. 2003 Aug; 46(4):245-8.
    View in: PubMed
    Score: 0.005
  112. Endemic or regionally limited bacterial and viral infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review. Lancet Haematol. 2023 Apr; 10(4):e284-e294.
    View in: PubMed
    Score: 0.004
  113. Endemic or regionally limited parasitic and fungal infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review. Lancet Haematol. 2023 Apr; 10(4):e295-e305.
    View in: PubMed
    Score: 0.004
  114. International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship. Elife. 2023 01 30; 12.
    View in: PubMed
    Score: 0.004
  115. The incidence and impact of clostridioides difficile infection on transplant outcomes in acute leukemia and MDS after allogeneic hematopoietic cell transplant-a CIBMTR study. Bone Marrow Transplant. 2023 04; 58(4):360-366.
    View in: PubMed
    Score: 0.004
  116. A new normal for the clinician's third hand: Stethoscope hygiene and infection prevention. Am J Infect Control. 2023 01; 51(1):114-118.
    View in: PubMed
    Score: 0.004
  117. Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022). Transplant Cell Ther. 2022 12; 28(12):810-821.
    View in: PubMed
    Score: 0.004
  118. Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial. Clin Infect Dis. 2022 09 10; 75(4):690-701.
    View in: PubMed
    Score: 0.004
  119. Comparative clinical manifestations and immune effects of cytomegalovirus infections following distinct types of immunosuppression. Clin Microbiol Infect. 2022 Oct; 28(10):1335-1344.
    View in: PubMed
    Score: 0.004
  120. Venous thrombosis associated with peripherally inserted central catheters: a retrospective analysis of the Cleveland Clinic experience. Clin Infect Dis. 2002 May 01; 34(9):1179-83.
    View in: PubMed
    Score: 0.004
  121. Human herpesvirus 6. Cleve Clin J Med. 2002 Jan; 69(1):92.
    View in: PubMed
    Score: 0.004
  122. A case of zygomycosis and invasive candidiasis involving the epiglottis and tongue in an immunocompromised patient. Scand J Infect Dis. 2002; 34(2):149-51.
    View in: PubMed
    Score: 0.004
  123. American Society for Transplantation and Cellular Therapy Series: #4 - Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation. Transplant Cell Ther. 2021 12; 27(12):957-967.
    View in: PubMed
    Score: 0.004
  124. American Society for Transplantation and Cellular Therapy Series: #3-Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation. Transplant Cell Ther. 2021 09; 27(9):707-719.
    View in: PubMed
    Score: 0.004
  125. Rapid diagnosis of Histoplasma capsulatum endocarditis using the AccuProbe on an excised valve. J Clin Microbiol. 2001 Jul; 39(7):2640-1.
    View in: PubMed
    Score: 0.004
  126. A young woman with fever, headache, and lymphadenopathy. Cleve Clin J Med. 2001 Jul; 68(7):584, 586-7, 591-93.
    View in: PubMed
    Score: 0.004
  127. Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation. Br J Haematol. 2021 07; 194(1):145-157.
    View in: PubMed
    Score: 0.004
  128. Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis. Blood. 2021 06 10; 137(23):3291-3305.
    View in: PubMed
    Score: 0.004
  129. Humoral and Mucosal Antibody Response to RSV Structural Proteins in RSV-Infected Adult Hematopoietic Cell Transplant (HCT) Recipients. Viruses. 2021 05 26; 13(6).
    View in: PubMed
    Score: 0.004
  130. How to interpret and use COVID-19 serology and immunology tests. Clin Microbiol Infect. 2021 Jul; 27(7):981-986.
    View in: PubMed
    Score: 0.004
  131. Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation. J Clin Oncol. 2021 08 20; 39(24):2710-2719.
    View in: PubMed
    Score: 0.004
  132. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. Lancet Haematol. 2021 Mar; 8(3):e185-e193.
    View in: PubMed
    Score: 0.004
  133. A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract. Clin Infect Dis. 2020 12 31; 71(11):2787-2795.
    View in: PubMed
    Score: 0.004
  134. Cost-effectiveness analysis of cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplant recipients from a US payer perspective. J Med Virol. 2021 06; 93(6):3786-3794.
    View in: PubMed
    Score: 0.004
  135. Deactivation of SARS-CoV-2 with pulsed-xenon ultraviolet light: Implications for environmental COVID-19 control. Infect Control Hosp Epidemiol. 2021 02; 42(2):127-130.
    View in: PubMed
    Score: 0.004
  136. Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients. Biol Blood Marrow Transplant. 2020 11; 26(11):1983-1994.
    View in: PubMed
    Score: 0.004
  137. Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee. Biol Blood Marrow Transplant. 2020 12; 26(12):2181-2189.
    View in: PubMed
    Score: 0.004
  138. Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2020 Oct; 22(5):e13395.
    View in: PubMed
    Score: 0.004
  139. A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation. Clin Infect Dis. 2020 04 10; 70(8):1525-1533.
    View in: PubMed
    Score: 0.004
  140. Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation. Antimicrob Agents Chemother. 2020 03 24; 64(4).
    View in: PubMed
    Score: 0.004
  141. Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans. J Infect Dis. 2020 02 03; 221(4):636-646.
    View in: PubMed
    Score: 0.004
  142. Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation. Am J Transplant. 2020 06; 20(6):1703-1711.
    View in: PubMed
    Score: 0.004
  143. Progression of the Radiologic Severity Index is associated with increased mortality and healthcare resource utilisation in acute leukaemia patients with pneumonia. BMJ Open Respir Res. 2019; 6(1):e000471.
    View in: PubMed
    Score: 0.004
  144. Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transplant. 2019 11; 25(11):e321-e330.
    View in: PubMed
    Score: 0.003
  145. Postoperative Urinary Tract Infection Quality Assessment and Improvement: The S.T.O.P. UTI Program and Its Impact on Hospitalwide CAUTI Rates. Jt Comm J Qual Patient Saf. 2019 10; 45(10):686-693.
    View in: PubMed
    Score: 0.003
  146. Refinement of estimates of mortality risk using the Radiologic Severity Index in hematologic malignancy patients with respiratory syncytial virus infection. Transpl Infect Dis. 2019 Aug; 21(4):e13105.
    View in: PubMed
    Score: 0.003
  147. Current drug therapy for multiple myeloma. Drugs. 1999 Apr; 57(4):485-506.
    View in: PubMed
    Score: 0.003
  148. Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults. Front Immunol. 2019; 10:706.
    View in: PubMed
    Score: 0.003
  149. HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant. Curr Res Transl Med. 2019 05; 67(2):51-55.
    View in: PubMed
    Score: 0.003
  150. Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant. 2019 04; 25(4):800-809.
    View in: PubMed
    Score: 0.003
  151. A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 02; 25(2):369-381.
    View in: PubMed
    Score: 0.003
  152. Progression of the Radiologic Severity Index predicts mortality in patients with parainfluenza virus-associated lower respiratory infections. PLoS One. 2018; 13(5):e0197418.
    View in: PubMed
    Score: 0.003
  153. Comparison of Palivizumab-Like Antibody Binding to Different Conformations of the RSV F Protein in RSV-Infected Adult Hematopoietic Cell Transplant Recipients. J Infect Dis. 2018 03 28; 217(8):1247-1256.
    View in: PubMed
    Score: 0.003
  154. Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study. Transpl Int. 2018 06; 31(6):639-648.
    View in: PubMed
    Score: 0.003
  155. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation. N Engl J Med. 2017 12 21; 377(25):2433-2444.
    View in: PubMed
    Score: 0.003
  156. Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018 02; 24(2):353-358.
    View in: PubMed
    Score: 0.003
  157. Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centers. J Med Virol. 2018 01; 90(1):50-60.
    View in: PubMed
    Score: 0.003
  158. Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial. Biol Blood Marrow Transplant. 2017 Mar; 23(3):512-521.
    View in: PubMed
    Score: 0.003
  159. Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients. Transpl Infect Dis. 2017 Feb; 19(1).
    View in: PubMed
    Score: 0.003
  160. Staphylococcus lugdunensis infections, filling in the gaps: a 3-year retrospective review from a comprehensive cancer center. Support Care Cancer. 2017 04; 25(4):1063-1069.
    View in: PubMed
    Score: 0.003
  161. Association of increased influenza vaccination in health care workers with a reduction in nosocomial influenza infections in cancer patients. Am J Infect Control. 2016 09 01; 44(9):1016-21.
    View in: PubMed
    Score: 0.003
  162. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia. Cancer. 2016 07 15; 122(14):2186-96.
    View in: PubMed
    Score: 0.003
  163. Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis. PLoS One. 2015; 10(11):e0139851.
    View in: PubMed
    Score: 0.003
  164. General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation. Biol Blood Marrow Transplant. 2015 Jul; 21(7):1284-90.
    View in: PubMed
    Score: 0.003
  165. Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trial. Ann Intern Med. 2015 Jan 06; 162(1):1-10.
    View in: PubMed
    Score: 0.003
  166. Topical cidofovir-induced acute kidney injury in two severely immunocompromised patients with refractory multidrug-resistant herpes simplex virus infections. J Oncol Pharm Pract. 2016 Apr; 22(2):325-31.
    View in: PubMed
    Score: 0.003
  167. Utility of routine surveillance blood cultures in asymptomatic allogeneic hematopoietic stem cell transplant recipients with indwelling central venous catheters at a comprehensive cancer center. Am J Infect Control. 2014 Oct; 42(10):1084-8.
    View in: PubMed
    Score: 0.002
  168. Infection with novel respiratory syncytial virus genotype Ontario (ON1) in adult hematopoietic cell transplant recipients, Texas, 2011-2013. J Infect Dis. 2015 Feb 15; 211(4):582-9.
    View in: PubMed
    Score: 0.002
  169. Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation. N Engl J Med. 2014 May 08; 370(19):1781-9.
    View in: PubMed
    Score: 0.002
  170. Timing of infectious complications following breast-conserving therapy with catheter-based accelerated partial breast irradiation. Ann Surg Oncol. 2014 Aug; 21(8):2512-6.
    View in: PubMed
    Score: 0.002
  171. Efficacy and safety of antiretrovirals in HIV-infected patients with cancer. Clin Microbiol Infect. 2014 Oct; 20(10):O672-9.
    View in: PubMed
    Score: 0.002
  172. The impact of pre-transplant valganciclovir on early cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation. J Oncol Pharm Pract. 2014 Aug; 20(4):257-62.
    View in: PubMed
    Score: 0.002
  173. Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience. Bone Marrow Transplant. 2013 Sep; 48(9):1218-23.
    View in: PubMed
    Score: 0.002
  174. Hospital-onset Clostridium difficile infection rates in persons with cancer or hematopoietic stem cell transplant: a C3IC network report. Infect Control Hosp Epidemiol. 2012 Nov; 33(11):1162-5.
    View in: PubMed
    Score: 0.002
  175. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol. 2012 Dec; 57(6):1177-85.
    View in: PubMed
    Score: 0.002
  176. Development and validation of a novel stratification tool for identifying cancer patients at increased risk of surgical site infection. Ann Surg. 2012 Jan; 255(1):134-9.
    View in: PubMed
    Score: 0.002
  177. Panton Valentine Leukocidin exotoxin has no effect on the outcome of cancer patients with methicillin-resistant Staphylococcus aureus (MRSA) infections. Medicine (Baltimore). 2011 Sep; 90(5):312-318.
    View in: PubMed
    Score: 0.002
  178. Evaluation and management of BK virus-associated nephropathy following allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2011 Nov; 17(11):1589-93.
    View in: PubMed
    Score: 0.002
  179. Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial. Lancet Infect Dis. 2011 Apr; 11(4):284-92.
    View in: PubMed
    Score: 0.002
  180. Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med. 2011 Feb; 39(2):245-51.
    View in: PubMed
    Score: 0.002
  181. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents. 2010 Aug; 36(2):182-6.
    View in: PubMed
    Score: 0.002
  182. Multistate outbreak of Serratia marcescens bloodstream infections caused by contamination of prefilled heparin and isotonic sodium chloride solution syringes. Arch Intern Med. 2009 Oct 12; 169(18):1705-11.
    View in: PubMed
    Score: 0.002
  183. Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention. Bone Marrow Transplant. 2010 Feb; 45(2):339-47.
    View in: PubMed
    Score: 0.002
  184. Multidrug-resistant Escherichia coli bacteremia in cancer patients. Am J Infect Control. 2009 Nov; 37(9):741-5.
    View in: PubMed
    Score: 0.002
  185. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients. Am J Infect Control. 2009 Aug; 37(6):442-6.
    View in: PubMed
    Score: 0.002
  186. Severe parainfluenza virus type 2 supraglottitis in an immunocompetent adult host: an unusual cause of a paramyxoviridae viral infection. J Intern Med. 2009 Mar; 265(3):397-400.
    View in: PubMed
    Score: 0.002
  187. Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol. 2009 Jan; 47(1):129-33.
    View in: PubMed
    Score: 0.002
  188. The role of molecular methods in the prevention of nosocomial methicillin-resistant Staphylococcus aureus clusters in cancer patients. Am J Infect Control. 2008 Nov; 36(9):656-60.
    View in: PubMed
    Score: 0.002
  189. Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study. Blood. 2008 Jun 01; 111(11):5403-10.
    View in: PubMed
    Score: 0.002
  190. Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases. Eur J Clin Microbiol Infect Dis. 2008 May; 27(5):343-7.
    View in: PubMed
    Score: 0.002
  191. The role of vitamin B6 in the prevention of haematological toxic effects of linezolid in patients with cancer. J Antimicrob Chemother. 2008 Feb; 61(2):421-4.
    View in: PubMed
    Score: 0.002
  192. Infections in 100 cord blood transplantations: spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005. Medicine (Baltimore). 2007 Nov; 86(6):324-333.
    View in: PubMed
    Score: 0.002
  193. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study. Clin Ther. 2007 Sep; 29(9):1980-6.
    View in: PubMed
    Score: 0.002
  194. Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters. Eur J Clin Microbiol Infect Dis. 2007 Aug; 26(8):549-56.
    View in: PubMed
    Score: 0.002
  195. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Infect Control Hosp Epidemiol. 2007 Sep; 28(9):1054-9.
    View in: PubMed
    Score: 0.002
  196. Risk of bioaerosol contamination with Aspergillus species before and after cleaning in rooms filtered with high-efficiency particulate air filters that house patients with hematologic malignancy. Infect Control Hosp Epidemiol. 2007 Sep; 28(9):1066-70.
    View in: PubMed
    Score: 0.001
  197. Oral topical cidofovir: novel route of drug delivery in a severely immunosuppressed patient with refractory multidrug-resistant herpes simplex virus infection. Transpl Infect Dis. 2007 Sep; 9(3):256-9.
    View in: PubMed
    Score: 0.001
  198. Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies. Bone Marrow Transplant. 2007 Jul; 40(2):125-36.
    View in: PubMed
    Score: 0.001
  199. Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients. Antimicrob Agents Chemother. 2007 Jun; 51(6):1905-11.
    View in: PubMed
    Score: 0.001
  200. Fungal osteoarticular infections in patients treated at a comprehensive cancer centre: a 10-year retrospective review. Clin Microbiol Infect. 2006 Jul; 12(7):621-6.
    View in: PubMed
    Score: 0.001
  201. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica. 2006 Jul; 91(7):986-9.
    View in: PubMed
    Score: 0.001
  202. Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients. Eur J Clin Microbiol Infect Dis. 2006 Jun; 25(6):382-8.
    View in: PubMed
    Score: 0.001
  203. Culture-positive and culture-negative endocarditis in patients with cancer: a retrospective observational study, 1994-2004. Medicine (Baltimore). 2006 Mar; 85(2):86-94.
    View in: PubMed
    Score: 0.001
  204. Chest tube-related empyema due to methicillin-resistant Staphylococcus aureus: could the chest tube be coated with antiseptics? Infect Control Hosp Epidemiol. 2006 Feb; 27(2):195-7.
    View in: PubMed
    Score: 0.001
  205. Extrapulmonary tuberculosis active infection misdiagnosed as cancer: Mycobacterium tuberculosis disease in patients at a Comprehensive Cancer Center (2001-2005). Cancer. 2005 Dec 15; 104(12):2882-7.
    View in: PubMed
    Score: 0.001
  206. Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis. 2005 Dec; 5(12):775-85.
    View in: PubMed
    Score: 0.001
  207. Hospitalization of an oncology patient suspected of having severe acute respiratory syndrome: a setup for an infection control quagmire at a comprehensive cancer center. Cancer. 2003 Dec 15; 98(12):2738-9.
    View in: PubMed
    Score: 0.001
  208. Common community respiratory viruses in patients with cancer: more than just "common colds". Cancer. 2003 May 15; 97(10):2576-87.
    View in: PubMed
    Score: 0.001
  209. Pasteurella multocida urinary tract infection with molecular evidence of zoonotic transmission. Clin Infect Dis. 2003 Feb 15; 36(4):E58-60.
    View in: PubMed
    Score: 0.001
  210. Late complications of Candida (Torulopsis) glabrata fungemia: description of a phenomenon. Scand J Infect Dis. 2002; 34(11):817-8.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.